B

Biomm
BIOM3

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
R$1.23B
EV
R$1.23B
Shares Outstanding
126.84M
Beta
0.67

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biomm S.A.

gainify

B

Biomm S.A.

BIOM3

Biomm S.A. operates as a biotechnology company in Brazil. The company offers AFREZZA, a human insulin inhalation powder; GHEMAXAN, an enoxaparina sodica; GLARGILIN, a glargine insulin; WOSULIN R, a human insulin; WOSULIN N, an isophane insulin; HERZUMA, a trastuzumab;...

Sector

Healthcare

Industry

Biotechnology

CEO

Marchezini, Heraldo

Employees

130

IPO Date

2000-01-11

Headquarters

705 – Lagoa dos Ingleses, Avenida Regent, Alphaville, Nova Lima, Minas Gerais, 34018-000, Brazil

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved